<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">Int J Cancer</journal-id><journal-id journal-id-type="iso-abbrev">Int J Cancer</journal-id><journal-id journal-id-type="pmc-domain-id">319</journal-id><journal-id journal-id-type="pmc-domain">nihpa</journal-id><journal-title-group><journal-title>International journal of cancer</journal-title></journal-title-group><issn pub-type="ppub">0020-7136</issn><issn pub-type="epub">1097-0215</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>NIHPA Author Manuscripts</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10182245</article-id><article-id pub-id-type="pmcid-ver">PMC10182245.319</article-id><article-id pub-id-type="pmcaid">10182245</article-id><article-id pub-id-type="pmcaiid">10182245</article-id><article-id pub-id-type="manuscript-id">NIHMS1886116</article-id><article-id pub-id-type="pmid">36916144</article-id><article-id pub-id-type="doi">10.1002/ijc.34510</article-id><article-id pub-id-type="manuscript-id-alternative">NIHMS1886116</article-id><article-id pub-id-type="manuscript-id-alternative">NIHPA1886116</article-id><article-version article-version-type="pmc-version">319</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>A rare <italic toggle="yes">FGF5</italic> candidate variant (rs112475347) for predisposition to non-squamous, non-small-cell lung cancer</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Cannon-Albright</surname><given-names initials="LA">Lisa A</given-names></name><xref rid="A1" ref-type="aff">1</xref><xref rid="A2" ref-type="aff">2</xref><xref rid="A3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Teerlink</surname><given-names initials="CC">Craig C</given-names></name><xref rid="A1" ref-type="aff">1</xref><xref rid="A3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Stevens</surname><given-names initials="J">Jeff</given-names></name><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Facelli</surname><given-names initials="JC">Julio C</given-names></name><xref rid="A4" ref-type="aff">4</xref><xref rid="A5" ref-type="aff">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Carr</surname><given-names initials="SR">Shamus R</given-names></name><xref rid="A6" ref-type="aff">6</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Allen-Brady</surname><given-names initials="K">Kristina</given-names></name><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Puri</surname><given-names initials="S">Sonam</given-names></name><xref rid="A2" ref-type="aff">2</xref><xref rid="A8" ref-type="aff">8</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Bailey-Wilson</surname><given-names initials="JE">Joan E</given-names></name><xref rid="A7" ref-type="aff">7</xref></contrib><contrib contrib-type="author"><collab>Genetic Epidemiology of Lung Cancer Consortium</collab><xref rid="FN1" ref-type="author-notes">*</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Akerley</surname><given-names initials="W">Wallace</given-names></name><xref rid="A2" ref-type="aff">2</xref><xref rid="A8" ref-type="aff">8</xref></contrib></contrib-group><aff id="A1"><label>1</label>Genetic Epidemiology, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah</aff><aff id="A2"><label>2</label>Huntsman Cancer Institute, Salt Lake City, Utah</aff><aff id="A3"><label>3</label>George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City, Utah</aff><aff id="A4"><label>4</label>Department of BioMedical Informatics, University of Utah School of Medicine, Salt Lake City, Utah</aff><aff id="A5"><label>5</label>Clinical and Translational Science Institute, University of Utah School of Medicine, Salt Lake City, Utah</aff><aff id="A6"><label>6</label>Thoracic Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland</aff><aff id="A7"><label>7</label>Computational and Statistical Genomics Branch, National Human Genome Research Institute, National Institutes of Health, Baltimore MD</aff><aff id="A8"><label>8</label>Medical Oncology, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah</aff><author-notes><fn id="FN1"><label>*</label><p id="P1">GELCC authorship list: Anthony M. Musolf<sup>1</sup>, Bilal A. Moiz<sup>1</sup>, Haiming Sun<sup>1,2</sup>, Claudio W. Pikielny<sup>3</sup>, Yohan Boss&#233;<sup>4</sup>, Diptasri Mandal<sup>5</sup>, Mariza de Andrade<sup>6</sup>, Colette Gaba<sup>7</sup>, Ping Yang<sup>8</sup>, Yafang Li<sup>9</sup>, Ming You<sup>10</sup>, Ramaswamy Govindan<sup>11</sup>, Richard K. Wilson<sup>12</sup>, Elena Y. Kupert<sup>10</sup>, Marshall W. Anderson<sup>10</sup>, Ann G. Schwartz<sup>13</sup>, Susan M. Pinney<sup>14</sup>, Christopher I. Amos<sup>9</sup>, and Joan E. Bailey-Wilson<sup>1</sup></p><p id="P2">1Computational and Statistical Genomics Branch, National Human Genome Research Institute, National Institutes of Health, Baltimore, Maryland. 2Laboratory of Medical Genetics, Harbin Medical University, Harbin, China. 3Geisel School of Medicine, Dartmouth College, Lebanon, New Hampshire. 4Institut universitaire de cardiologie et de pneumologie de Qu&#233;bec, Department of Molecular Medicine, Laval University, Quebec City, Quebec, Canada. 5Department of Genetics, Louisiana State University Health Sciences Center, New Orleans, Louisiana. 6Mayo Clinic, Rochester, Minnesota. 7Department of Medicine, University of Toledo, Toledo, Ohio. 8Mayo Clinic, Scottsdale, Arizona. 9Baylor College of Medicine, Houston, Texas. 10Medical College of Wisconsin, Milwaukee, Wisconsin. 11Division of Oncology, Washington University School of Medicine, St. Louis, Missouri. 12Institute for Genomic Medicine, Nationwide Children&#8217;s Hospital, Columbus, Ohio. 13Karmanos Cancer Institute, Wayne State University, Detroit, Michigan. 14Department of Environmental and Public Health Sciences, University of Cincinnati College of Medicine, Cincinnati, Ohio.</p></fn><fn fn-type="con" id="FN2"><p id="P3">AUTHOR CONTRIBUTIONS</p><p id="P4">The work reported in the paper has been performed by the authors, unless clearly specified in the text. <bold>LA Cannon-Albright:</bold> conceptualization, methodology, investigation, resources, data curation, writing original draft, review and editing, supervision, project administration, funding acquisition. <bold>CC Teerlink</bold>: methodology, validation, formal analysis, data curation, writing original draft, review and editing. <bold>J Stevens</bold>: methodology, validation, formal analysis, data curation, writing original draft, review and editing. <bold>JC Facelli</bold>: methodology, validation, formal analysis, data curation, writing original draft, review and editing, visualization<sup>.</sup>
<bold>SR Carr</bold>: resources, writing review and editing. <bold>K Allen-Brady</bold>: resources, writing review and editing. <bold>S Puri</bold>: resources, writing review and editing. <bold>JE Bailey-Wilson</bold>: validation, resources, data curation, writing original draft, review and editing, supervision, funding acquisition. <bold>AM Musolf</bold>: validation, resources, data curation, writing original draft, review and editing, <bold>Genetic Epidemiology of Lung Cancer Consortium Authors</bold>*: validation, resources, data curation, writing review and editing. <bold>W Akerley:</bold> resources, writing review and editing, funding acquisition.</p><p id="P8">*Anthony M. Musolf, Bilal A. Moiz, Haiming Sun, Claudio W. Pikielny, Yohan Boss&#233;, Diptasri Mandal, Mariza de Andrade, Colette Gaba, Ping Yang, Yafang Li, Ming You, Ramaswamy Govindan, Richard K. Wilson, Elena Y. Kupert, Marshall W. Anderson, Ann G. Schwartz, Susan M. Pinney, Christopher I. Amos, and Joan E. Bailey-Wilson</p></fn><corresp id="CR1"> Corresponding author: LA Cannon-Albright, PhD, Genetic Epidemiology, 295 Williams Building, Research Park, Salt Lake City, UT 84108, <email>lisa.albright@utah.edu</email>, 801 587 9300</corresp><fn fn-type="COI-statement" id="FN4"><p id="P37"><underline>Conflict of Interest</underline> Author SP declares an advising/consultant relationship with AstraZeneca, G1 Therapeutics, and Jazz Pharma. The other authors have no conflict of interest to declare.</p></fn></author-notes><pub-date pub-type="ppub"><day>15</day><month>7</month><year>2023</year></pub-date><pub-date pub-type="epub"><day>05</day><month>4</month><year>2023</year></pub-date><volume>153</volume><issue>2</issue><issue-id pub-id-type="pmc-issue-id">435720</issue-id><fpage>364</fpage><lpage>372</lpage><pub-history><event event-type="nihms-submitted"><date><day>05</day><month>04</month><year>2023</year></date></event><event event-type="pmc-release"><date><day>15</day><month>07</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>15</day><month>07</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-09-21 16:25:26.393"><day>21</day><month>09</month><year>2024</year></date></event></pub-history><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-1886116.pdf"/><abstract id="ABS1"><p id="P9">A unique approach with rare resources was used to identify candidate variants predisposing to familial non-squamous non-small-cell lung cancers (NSNSCLC). We analyzed sequence data from NSNSCLC-affected cousin pairs belonging to high-risk lung cancer pedigrees identified in a genealogy of Utah linked to statewide cancer records to identify rare, shared candidate predisposition variants. Variants were tested for association with lung cancer risk in UKBiobank. Evidence for linkage with lung cancer was also reviewed in families from the Genetic Epidemiology of Lung Cancer Consortium. Protein prediction modeling compared the mutation with reference. We sequenced NSNSCLC-affected cousin pairs from 8 high-risk lung cancer pedigrees and identified 66 rare candidate variants shared in the cousin pairs. One variant in the <italic toggle="yes">FGF5</italic> gene also showed significant association with lung cancer in UKBiobank. This variant was observed in 3/163 additional sampled Utah lung cancer cases, 2 of whom were related in another independent pedigree. Modeling of the predicted protein predicted a second binding site for SO<sub>4</sub> that may indicate binding differences. This unique study identified multiple candidate predisposition variants for NSNSCLC, including a rare variant in <italic toggle="yes">FGF5</italic> that was significantly associated with lung cancer risk and that segregated with lung cancer in the two pedigrees in which it was observed. <italic toggle="yes">FGF5</italic> is an oncogenic factor in several human cancers, and the mutation found here (W81C) changes the binding ability of heparan sulfate to FGF5, which might lead to its deregulation. These results support <italic toggle="yes">FGF5</italic> as a potential NSNSCLC predisposition gene and present additional candidate predisposition variants.</p></abstract><kwd-group><kwd>non-squamous non-small cell lung cancer</kwd><kwd>UPDB</kwd><kwd>pedigree</kwd><kwd>predisposition</kwd><kwd><italic toggle="yes">FGF5</italic></kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>